Stock Events

Stock Events

Prostatype Genomics AB 

0
2
+SEK0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-7,492.09%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
594,000Revenue
-44.5MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Myriad Genetics
MYGN
Mkt Cap607.38M
Myriad Genetics provides molecular diagnostic products that include prognostic medicine for prostate cancer, directly competing with Prostatype Genomics' offerings.
Illumina
ILMN
Mkt Cap35.63B
Illumina manufactures sequencing systems that are used in cancer genomics, impacting the broader market including prostate cancer diagnostics.
Fulgent Genetics
FLGT
Mkt Cap567.37M
Fulgent Genetics offers comprehensive genetic testing, including for cancer, which places them in direct competition with Prostatype Genomics in the genomic profiling market.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences offers sequencing technologies that are used in genomic research, including cancer, indirectly competing with Prostatype Genomics.
Qiagen NV
QGEN
Mkt Cap10.37B
Qiagen provides sample to insight solutions including for cancer, with technologies that compete in the genomic diagnostics market.
Quest Diagnostics
DGX
Mkt Cap27.79B
Quest Diagnostics offers diagnostic testing, including for cancers such as prostate cancer, competing with Prostatype Genomics in the diagnostics market.

About

PROSTATYPE GENOMICS AB
Show More
CEO
Country
Sweden
ISIN
SE0029529825

Listings

OTC Link
US
PGABF
ST
SE
PROGEN-BT-UN.ST
F
DE
PGO0.F
ST
SE
PROGEN.ST

0 Comments

Share your thoughts

FAQs

What is Prostatype Genomics AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Prostatype Genomics AB stocks are traded under the ticker PROGEN-BT-UN.ST.
What is Prostatype Genomics AB revenue for the last year?▼
Prostatype Genomics AB revenue for the last year amounts to 594,000 SEK.
What is Prostatype Genomics AB net income for the last year?▼
PROGEN-BT-UN.ST net income for the last year is -44.5M SEK.
In which sector is Prostatype Genomics AB located?▼
Prostatype Genomics AB operates in the Other sector.
When did Prostatype Genomics AB complete a stock split?▼
Prostatype Genomics AB has not had any recent stock splits.